OncoCyte releases positive data on lung cancer diagnostic study
OncoCyte Corporation (NYSE:OCX) CEO William Annett sat down with Proactive Investors at the BIO CEO & Investor Conference in New York.
Annett says recently, OncoCyte released positive data on its lung cancer diagnostic study.